2026-06-14T03:33:43Zhttps://repisalud.isciii.es/rest/oai/requestoai:repisalud.isciii.es:20.500.12105/51562024-09-27T09:20:35Zcom_20.500.12105_19604com_20.500.12105_2051col_20.500.12105_19605
Repisalud
author
Hausenloy, Derek J
author
Botker, Hans Erik
author
Engstrom, Thomas
author
Erlinge, David
author
Heusch, Gerd
author
Ibáñez, Borja
author
Kloner, Robert A.
author
Ovize, Michel
author
Yellon, Derek M.
author
Garcia-Dorado, David
funder
British Heart Foundation
funder
Rosetrees Trust
funder
National Institute for Health Research (Reino Unido)
funder
Centro de Investigación Biomédica en Red - CIBERCV (Enfermedades Cardiovasculares)
funder
Deutsche Forschungsgemeinschaft (Alemania)
funder
Instituto de Salud Carlos III
funder
Unión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF)
2017-10-20T10:33:49Z
2017-10-20T10:33:49Z
2017
Eur Heart J. 2017; 38(13):935-941
10.1093/eurheartj/ehw145
1522-9645
0195-668X
European Heart Journal
27118196
http://hdl.handle.net/20.500.12105/5156
eng
PERCUTANEOUS CORONARY INTERVENTION
RANDOMIZED CONTROLLED-TRIAL
MITOCHONDRIAL PERMEABILITY TRANSITION
CONTROLLED CLINICAL-TRIAL
LEFT-VENTRICULAR FUNCTION
BYPASS GRAFT-SURGERY
NO-REFLOW PHENOMENON
LONG-TERM BENEFIT
PROTEIN KINASE-C
ISCHEMIA-REPERFUSION
Targeting reperfusion injury in patients with ST-segment elevation myocardial infarction: trials and tribulations
journal article
URL
https://repisalud.isciii.es/bitstreams/aadd4ae3-e662-48ad-b8f1-62a35c3ac900/download
File
MD5
148b688b91ac8d469c4ba84dee4493b9
309765
application/pdf
TargetingReperfusionInjuryIn_2017
URL
https://repisalud.isciii.es/bitstreams/6ffdac24-d638-4be6-9d18-0584d0b9285f/download
File
MD5
9b4b95544eb2a5f7292fe03fc0af4a86
77387
text/plain
TargetingReperfusionInjuryIn_2017.pdf.txt
URL
https://repisalud.isciii.es/bitstreams/56d2143d-fc73-4d5d-ae0c-897b26d7afd0/download
File
MD5
9b4b95544eb2a5f7292fe03fc0af4a86
77387
text/plain
TargetingReperfusionInjuryIn_2017.txt